Research & Trials
TMC435-TiDP16-C205: A Phase II Study of TMC435 in Combination With Pegylated Interferon Alpha-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment
1 April 2009The purpose of this study is to test the efficacy, safety and tolerability of 4 different regimens of TMC435 given in combination with Peginterferon alfa-2a and ribaviron (Standard of Care) as ... › More
Ultrabrief Pulsewidth Electroconvulsive Therapy (ECT) (UB ECT)
26 March 2009Electroconvulsive Therapy (ECT) remains essential to contemporary psychiatric practice and is one of the safest and most effective treatments available for depression. Despite modern advances in ... › More
Techniques to Improve Efficacy of Second Trimester Medical Termination
2 March 2009Interruption of a pregnancy after 14 weeks gestation may be required when the foetus is dead, severely malformed or in cases of maternal illness. This process is usually conducted medically in ... › More
Repeat Dose Safety Study for Compound to Treat Anaemia
18 February 2009The purpose of this study is to characterise the safety and tolerability of repeat doses of compound 1278863A in healthy subjects. › More
Melancholic Depression Treatment Trial
5 February 2009The Black Dog Institute is currently running a treatment trial for individuals who are currently experiencing melancholic depression. The trial consists of three separate treatments which include: ... › More
An Open Label Extension Study in Patients With Rheumatoid Arthritis
3 February 2009To evaluate the safety and tolerability of LY2127399 administered as subcutaneous injections for 48 weeks in patients with rheumatoid arthritis. › More
Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population
22 January 2009This is a phase IV, open label, multi-centre study to evaluate the safety and tolerability of CSL Limited's influenza virus vaccine in a paediatric population aged ≥ 6 months to < 18 ... › More
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
1 January 2009The purpose of this study is to evaluate the safety and effectiveness of the PROMUS ElementTM Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo ... › More
A Study Evaluating Safety and Immunogenicity of Meningococcal B rLP2086 Vaccine in Adolescents
12 December 2008The purpose of this study is to evaluate the safety and immunogenicity of an investigational meningococcal B rLP2086 vaccine in adolescents aged 11 to 18 years old. › More
Lume Lung 2: BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
10 December 2008The trial will be performed to evaluate if BIBF 1120 in combination with standard pemetrexed therapy is more effective than placebo (inactive capsule) plus standard pemetrexed therapy in patients ... › More
